ACOG+31.08%14.3%
MREO-27.17%14.3%
MTSR0.00%14.3%
RZLT+98.31%14.3%
SUPN-5.61%14.3%
VERA-40.07%14.3%
VYGR-21.12%14.3%
As of Aug 6, 2026, 4:25 AM ET
Biotech '25: Neurology, CNS & Rare Disorders Constituents
Alpha Cognition IncACOG | 14.3% | -4.70% | 7.85% | 7.85% | 2.90% | 31.08% | 42.00% | 67.72% | -8.88% | $132.3M |
Mereo BioPharma Group plcMREO | 14.3% | -5.77% | 5.46% | -4.26% | -11.52% | -27.17% | -18.11% | -87.19% | -80.91% | $48.4M |
Metsera, Inc.MTSR | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.04% | -0.33% | $3.51B |
Rezolute, Inc.RZLT | 14.3% | -5.84% | -6.21% | -5.07% | -0.85% | 98.31% | 45.79% | 54.97% | -17.75% | $450.6M |
Supernus Pharmaceuticals, Inc.SUPN | 14.3% | 8.46% | 1.54% | -0.70% | 5.11% | -5.61% | -14.29% | 42.93% | 10.53% | $2.72B |
Vera Therapeutics, Inc.VERA | 14.3% | 1.34% | -14.39% | -24.37% | -5.45% | -40.07% | -25.59% | 28.66% | 57.66% | $2.18B |
Voyager Therapeutics, Inc.VYGR | 14.3% | -0.80% | 0.00% | -14.36% | 2.31% | -21.12% | -24.39% | -9.09% | -8.82% | $187.3M |
| Theme return | — | -1.04% | -0.82% | -6.29% | 0.72% | 8.01% | 3.63% | 94.07% | 49.80% | — |
| Average | 14.3% | -1.04% | -0.82% | -5.84% | -1.07% | 5.06% | 0.77% | 20.72% | -6.93% | $1.32B |
| Median | 14.3% | -0.80% | 0.00% | -4.26% | 0.00% | -5.61% | -14.29% | 42.93% | -8.82% | $450.6M |
| Std Dev | 0.0% | 4.72% | 6.91% | 9.76% | 5.28% | 43.54% | 28.38% | 49.52% | 38.02% | $1.34B |
| Min | 14.3% | -5.84% | -14.39% | -24.37% | -11.52% | -40.07% | -25.59% | -87.19% | -80.91% | $48.4M |
| Max | 14.3% | 8.46% | 7.85% | 7.85% | 5.11% | 98.31% | 45.79% | 67.72% | 57.66% | $3.51B |
| % Positive Tickers | 28.57% | 42.86% | 14.29% | 42.86% | 28.57% | 28.57% | 71.43% | 28.57% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '25: Neurology, CNS & Rare Disorders tracks 7 publicly listed stocks in this theme: ACOG, MREO, MTSR, RZLT, SUPN, VERA, VYGR. See the constituent table for details.